Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07213700
Recruiting
InRAD Observational Study
Not applicable · Austria, Australia, Belgium, Brazil, Czechia, Egypt, Spain, Greece, Ireland, Italy, Netherlands, Poland, Portugal, Romania, Saudi Arabia, Türkiye, Taiwan · 23 sites
Registry update: 6 Nov 2026
NCT07208331
Recruiting
Evaluation of an Integrated, Digital, Nurse-led, Remote Monitoring Care Pathway for Cardiovascular Risk Management
Not applicable · Netherlands · 1 site
Registry update: 9 Oct 2026
NCT07508020
Recruiting
A Research Study Looking at How NNC0487-0111 Affects Food Intake, Appetite and Metabolism After Meals in People With Obesity
Phase 1 · Germany · 1 site
Registry update: 27 Apr 2026
NCT06745050
Recruiting
Hybrid Type-1 Effectiveness-Implementation Trial of Motivation Matters!
Not applicable · Kenya · 1 site
Registry update: 12 May 2026
NCT07312734
Recruiting
Study to Enable New Diagnostics for Pulmonary Microbes in People With CF
Not applicable · United States · 9 sites
Registry update: 2 Jul 2026
NCT07560488
Recruiting
Ipilimumab N01 Combined With Sintilimab, Bevacizumab Biosimilar, and Hepatic Arterial Infusion Chemotherapy as Conversion Therapy for Unresectable Intermediate-Advanced Hepatocellular Carcinoma
Phase 2 · China · 1 site
Registry update: 1 May 2026
NCT07530198
Recruiting
HIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong
Phase 1 · Hong Kong · 1 site
Registry update: 15 Apr 2026
NCT07501299
Recruiting
HeartBeam ECG Registry
Not applicable · United States · 1 site
Registry update: 20 Jul 2026
NCT07329322
Recruiting
Phase II Study of Sacituzumab Tirumotecan in Combination With Osimertinib for Neoadjuvant Treatment in Patients With Resectable Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Phase 2 · China · 1 site
Registry update: 20 Aug 2026
NCT07042919
Recruiting
Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer
Phase 1/2 · United States · 1 site
Registry update: 23 Oct 2026
NCT07269717
Recruiting
A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved Ejection Fraction
Phase 2 · China · 1 site
Registry update: 11 May 2026
NCT06889610
Recruiting
A Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors.
Phase 2 · China · 1 site
Registry update: 13 Jul 2026
NCT07238556
Recruiting
A Novel Digital Tool Clinicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors
Not applicable · United States · 3 sites
Registry update: 16 Oct 2026
NCT07679542
Recruiting
Dihydroartemisinin for MAFLD
Phase 1/2 · China · 1 site
Registry update: 1 Jul 2026
NCT07779109
Recruiting
Pelvic Ultra-Hypofractionated Adjuvant Radiotherapy for Endometrial Cancer (PURE-cohort)
Not applicable · Spain · 1 site
Registry update: 25 Aug 2026
2024-516544-26-00
Recruiting
Local Tenecteplase ApplicatiOn subsequent to endovasCular Recanalization in Anterior CircuLation Stroke - the LOCAL trial
Phase 2 · Germany · 15 sites
Registry update: 8 Oct 2026
NCT07402577
Recruiting
Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility Study
Not applicable · United States · 1 site
Registry update: 15 Apr 2026
NCT07054489
Recruiting
UPBEAT: Using Polygenic Scores to Guide BB Therapy in HF With Mildly Reduced EF
Not applicable · United States · 1 site
Registry update: 7 Jul 2026
NCT07495904
Recruiting
Effect of GLP-1 Receptor Agonists on Body Composition in Obesity: The Role of Dietary Protein Consumption in Muscle Mass Maintenance
Not applicable · Greece · 2 sites
Registry update: 2 Apr 2026
NCT07535268
Recruiting
REPRESENT-PF Registry
Not applicable · United States · 2 sites
Registry update: 17 Apr 2026

Ordered by registry start date. Freshness and sponsorship never change the order.